76 related articles for article (PubMed ID: 518256)
1. Partial characterization of the E rosette restoring factor (RRF) from normal human serum.
Zwoliński J; Wieczorek Z; Skibiński G
Arch Immunol Ther Exp (Warsz); 1979; 27(4):469-73. PubMed ID: 518256
[TBL] [Abstract][Full Text] [Related]
2. Modulation of E rosette forming activity of human lymphocytes by rosette inhibiting factor (RIF) ann rosette restoring factor (RRF).
Skibiński G; Zwoliński J; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1979; 27(4):475-80. PubMed ID: 117784
[TBL] [Abstract][Full Text] [Related]
3. In vitro response to rosette inhibition factor (RIF) and rosette restoring factor (RRF) of human lymphocyte after fractionation on a discontinuous density albumin gradient.
Wieczorek Z; Skibiński G; Zwoliński J
Arch Immunol Ther Exp (Warsz); 1979; 27(4):481-6. PubMed ID: 117785
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human T lymphocyte rosette formation by serum factors.
Skibiński G; Wieczorek Z; Zwoliński J
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):351-6. PubMed ID: 35127
[TBL] [Abstract][Full Text] [Related]
5. Characterization of lymphocyte E rosette inhibitory factor in sera from tuberculous patients.
Wieczorek Z; Skibiński G; Zwoliński J
Arch Immunol Ther Exp (Warsz); 1977; 25(1):63-8. PubMed ID: 327969
[TBL] [Abstract][Full Text] [Related]
6. Effect of uremic serum on E-rosette formation of normal lymphocytes modulated by levamisole.
Modai D; Peller S; Weissgarten J; Shaked U; Kaufman S
Isr J Med Sci; 1981 Dec; 17(12):1115-8. PubMed ID: 7327910
[TBL] [Abstract][Full Text] [Related]
7. Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.
Luben RA; Mundy GR; Trummel CL; Raisz LG
J Clin Invest; 1974 May; 53(5):1473-80. PubMed ID: 4825237
[TBL] [Abstract][Full Text] [Related]
8. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
Michalevicz R; Many A; Ramot B; Trainin N
Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
[TBL] [Abstract][Full Text] [Related]
9. Isolation and purification of fetal calf serum factor promoting mouse erythrocyte rosette formation.
Venza Teti D; Misefari A; Sofo V; Santarpia G; La Via MF
Diagn Immunol; 1984; 2(1):44-7. PubMed ID: 6333961
[TBL] [Abstract][Full Text] [Related]
10. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
Zółtowska A; Arendt M; Gan J
Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
[TBL] [Abstract][Full Text] [Related]
11. [A study on the inhibitory effect of the serum from pulmonary tuberculosis patients on the E-rosette formation of normal T-cells (author's transl)].
Ikeda S; Shima K; Ando M; Tokuomi H
Kekkaku; 1980 Jan; 55(1):15-8. PubMed ID: 6966006
[No Abstract] [Full Text] [Related]
12. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
[TBL] [Abstract][Full Text] [Related]
13. The E-rosette augmenting factor (E-RAF): aspects of clinical application.
Agbata AI; Kirkpatrick CH
Clin Exp Immunol; 1980 Feb; 39(2):321-7. PubMed ID: 6966991
[TBL] [Abstract][Full Text] [Related]
14. Formation of total and stable E-rosettes by lymphocytes from patients with pulmonary tuberculosis stimulated by Con A or PPD.
Aristizábal L; García LF
J Clin Lab Immunol; 1985 Jan; 16(1):31-6. PubMed ID: 3981616
[TBL] [Abstract][Full Text] [Related]
15. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
Zarnegar R; Michalopoulos G
Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of E-rosette formation by mitogen-stimulated canine lymphocytes.
Krakowka S
Immunology; 1980 Feb; 39(2):255-61. PubMed ID: 7380469
[TBL] [Abstract][Full Text] [Related]
17. Factor released from human lymphocytes stimulated cholinergically in vitro: an E-rosetting inhibitor.
Bortkiewicz H; Ryzewski J
Int J Tissue React; 1989; 11(3):101-6. PubMed ID: 2613455
[TBL] [Abstract][Full Text] [Related]
18. Human helper T cell factor(s) (ThF). I. Partial purification and characterization.
Hirano T; Teranishi T; Toba H; Sakaguchi N; Fukukawa T; Tsuyuguchi I
J Immunol; 1981 Feb; 126(2):517-22. PubMed ID: 6161177
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an auto-rosette inhibitory fraction in mouse serum.
Hsu KH; Ghanta VK; Duncan LA; Hunt CE; Hiramoto RN
J Immunol; 1980 Sep; 125(3):1298-301. PubMed ID: 7410841
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of total and active E-rosettes mediated by serum from tubercular patients].
Dlugovitzky D; Luchessi S; Romano B; Molteni OA
Enferm Infecc Microbiol Clin; 1992 May; 10(5):255-8. PubMed ID: 1390993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
